FTI
45
-5
SCHW
53
-5
ED
34
-3
PEG
46
-2
UA
6
3
ADM
68
12
WDC
66
-4
NUE
65
5
ZION
52
-3
EQT
57
4
BMY
50
2
DUK
52
-2
HD
47
-2
GT
26
2
ISRG
50
2
TSN
54
2
NAVI
24
-5
HRB
44
3
BBY
60
8
AVB
42
2
FTI
45
-5
SCHW
53
-5
ED
34
-3
PEG
46
-2
UA
6
3
ADM
68
12
WDC
66
-4
NUE
65
5
ZION
52
-3
EQT
57
4
BMY
50
2
DUK
52
-2
HD
47
-2
GT
26
2
ISRG
50
2
TSN
54
2
NAVI
24
-5
HRB
44
3
BBY
60
8
AVB
42
2
Financhill
Back

iShares LifePath Target Date 2040 ETF Vs. Nektar Therapeutics Industry Stock Comparison

Buy
91

ITDD
iShares LifePath Target Date 2040 ETF

Last Price:
$33.93
Seasonality Move:
6.9%
Buy
62

NKTR
Nektar Therapeutics

Last Price:
$27.26
Seasonality Move:
4.65%
Buy
91
iShares LifePath Target Date 2040 ETF (ITDD) is a Buy

Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?

  • The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $33.95. The Score for ITDD is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
  • ITDD is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
62
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $27.26. The Score for NKTR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ITDD Stock Price Chart

What is iShares LifePath Target Date 2040 ETF's stock price today?

  • The iShares LifePath Target Date 2040 ETF share price today is $33.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDD is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $27.26
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.

ITDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 67.63 Buy
Chaikin Money Flow: 170 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.16 - 33.74) Buy
Bollinger Bands (100): (30.34 - 33.3) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.04 Buy
Relative Strength Index (14 RSI): 66.02 Buy
Chaikin Money Flow: -23288 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.49 - 25.51) Buy
Bollinger Bands (100): (8.3 - 22.66) Buy

ITDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.75 Buy
20-day SMA: 33.53 Buy
50-day SMA: 33.02 Buy
200-day SMA: 31.5 Buy
8-day EMA: 33.78 Buy
20-day EMA: 33.54 Buy
50-day EMA: 32.99 Buy
200-day EMA: 31.55 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.13 Buy
20-day SMA: 23.8 Buy
50-day SMA: 20.82 Buy
200-day SMA: 15.1 Buy
8-day EMA: 24.9 Buy
20-day EMA: 23.86 Buy
50-day EMA: 21.15 Buy
200-day EMA: 16.63 Buy

iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.

iShares LifePath Target Date 2040 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):